Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

Clinical trial NCT03895801 · COMPLETED

Trial details

NCT number: NCT03895801
Sponsor: InflaRx GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Granulomatosis With Polyangiitis (GPA)Microscopic Polyangiitis (MPA)

Start date: 2019-04-03
Primary completion: 2021-04-14
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.